2025-11-30 - Analysis Report
Okay, here's a comprehensive report on Honeywell International Inc. (HON) based on the data you've provided.

**1) Return Rate Comparison & Analysis**

*   **Company Overview:** Honeywell International Inc. is a diversified technology and manufacturing company serving customers worldwide with aerospace products and services, control technologies for buildings and industry, and performance materials.
*   **HON Cumulative Return:** 5.64%
*   **VOO (S&P 500) Cumulative Return:** 101.92%
*   **Divergence:** -90.2 (Relative Divergence: 3.0)

**Analysis:**

HON has significantly underperformed the S&P 500 (VOO) over the period covered by the cumulative returns. The divergence of -90.2 indicates a substantial performance gap. The relative divergence of 3.0 suggests that the current divergence is near the minimum end of its historical fluctuation range. This underperformance relative to the S&P 500 necessitates a deeper look into factors affecting Honeywell's growth.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 33.0%  | 67.3% | 5.0%   | -0.0 | 99.0   |
| 2016-2018  | 15.0%  | 71.0% | 0.0%   | 0.1  | 89.0   |
| 2017-2019  | 29.0%  | 71.1% | 7.0%   | 1.0  | 119.3  |
| 2018-2020  | 6.0%   | 79.4% | -18.0%  | 1.0  | 143.3  |
| 2019-2021  | 19.0%  | 79.4% | -28.0%  | 1.2  | 140.5  |
| 2020-2022  | 9.0%   | 79.4% | 10.0%   | 1.4  | 144.4  |
| 2021-2023  | -9.0%  | 77.9% | -10.0%  | 1.2  | 141.3  |
| 2022-2024  | -2.0%  | 79.7% | -22.0%  | 1.2  | 152.2  |
| 2023-2025  | -26.0% | 79.7% | -92.0%  | 2.0  | 129.5  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate has fluctuated significantly, with negative growth in recent periods (2021-2025).
*   **MDD:** The Maximum Drawdown remains high, consistently around 70-80%, indicating substantial risk.
*   **Alpha:**  Alpha has been negative in many recent periods, especially from 2018-2025, suggesting underperformance relative to the market's risk-adjusted return. A sharply negative Alpha of -92% from 2023-2025 is particularly concerning.
*   **Beta:** Beta generally hovers around 1.0-1.4, and jumps to 2.0 in 2023-2025 indicating that Honeywell's price tends to move in the same direction as the market, and recently it has amplified market movements even more.
*   **Cap(B):** Market capitalization shows an overall increasing trend until recently, with a decline in the latest period.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 192.19
*   **Previous Close:** 189.99
*   **Change:** 1.16
*   **5-day SMA:** 190.38
*   **20-day SMA:** 194.95
*   **60-day SMA:** 204.42

**Analysis:**

The current price is below both the 20-day and 60-day Simple Moving Averages (SMA), suggesting a short-term downtrend.  The recent positive change indicates a slight rebound.

**3) RSI, PPO, Market Risk Indicator (MRI) and Expected Return**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 46.85
*   **PPO:** -0.0755
*   **Hybrid Signal:** Buy 100% of cash (5 shares - Very Safe (OverSold Boost) - MRI:0.90)
*   **Recent Relative Divergence Change:** -1.0 (Short-term decline)
*   **Expected Return (%):** -977.1%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests that based on broad market conditions, it is a good time to invest.
*   **RSI:** An RSI of 46.85 indicates a neutral condition, neither overbought nor oversold.
*   **PPO:** A negative PPO suggests that the short-term moving average is below the long-term moving average, indicating a potential downtrend.
*   **Hybrid Signal:** The hybrid signal suggests a strong buy recommendation, based on the stock being oversold and a positive market risk environment.
*   **Recent Relative Divergence Change:** The recent decline in relative divergence points to short-term underperformance.
*   **Expected Return:** The extremely negative expected return is highly concerning and suggests that the model predicts very poor future performance compared to the S&P 500. This could be a model artifact but warrants serious investigation.

**4) Recent News & Significant Events**

*   **TD Cowen Reduces PT:** TD Cowen reduced the price target on HON.
*   **Grantham Mayo Van Otterloo & Co. LLC Acquires Shares:** A notable investment firm acquired shares of Honeywell.
*   **Analysts See 27% Upside Potential:** Multiple sources report analysts forecasting significant upside potential.
*   **Honeywell (HON) Stock Analysis: 2025 Performance & Market Outlook:** A general overview of Honeywell's recent performance.
*   **Honeywell Stock Near Key Levels:** An article discussing whether HON is a buy or if caution is warranted.

**Analysis:**

The news is mixed. The reduced price target is a negative signal. However, the share acquisition by a reputable firm and analysts' optimistic price targets are positive indicators. The other articles are general performance overviews. This suggests some disagreement or uncertainty regarding Honeywell's near-term prospects.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.00)
*   **Target Price:** Average: 241.67 / High: 271.00 / Low: 205.00
*   **Recent Rating Changes:** None provided.

**Analysis:**

Despite some negative news, the overall analyst consensus is to buy Honeywell. The average target price suggests a potential upside from the current price.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-23 | 2.87 | 10.41 B$   |
| 2025-07-24 | 2.46 | 10.35 B$   |
| 2025-04-29 | 2.24 | 9.82 B$    |
| 2024-10-24 | 2.17 | 9.73 B$    |
| 2025-10-23 | 2.17 | 9.73 B$    |

**Analysis:**
I've noted a duplicate entry on the table. Let's examine the data from 2024-10-24 to 2025-10-23:

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2024-10-24 | 2.17 | 9.73 B$    |
| 2025-04-29 | 2.24 | 9.82 B$    |
| 2025-07-24 | 2.46 | 10.35 B$   |
| 2025-10-23 | 2.87 | 10.41 B$   |

There's a clear upward trend in both Earnings Per Share (EPS) and Revenue over the last four quarters. This indicates improving financial performance.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $10.41B  | 34.08%        |
| 2025-06-30   | $10.35B  | 38.86%        |
| 2025-03-31   | $9.82B   | 38.54%        |
| 2024-12-31   | $10.09B  | 36.38%        |
| 2024-09-30   | $9.73B   | 38.54%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-09-30   | $16.78B  | 10.87% |
| 2025-06-30   | $16.09B  | 9.75%  |
| 2025-03-31   | $17.46B  | 8.30%  |
| 2024-12-31   | $18.62B  | 6.90%  |
| 2024-09-30   | $17.41B  | 8.12%  |

**Analysis:**

*   **Revenue:** Revenue shows a generally increasing trend over the past five quarters.
*   **Profit Margin:** Profit margins have fluctuated but remain strong.
*   **Equity:** Equity has generally been decreasing.
*   **ROE:** Return on Equity (ROE) has been increasing, reflecting improved profitability on shareholder equity.

**7) Comprehensive Analysis (Summary)**

Honeywell's stock (HON) has significantly underperformed the S&P 500. While recent earnings show positive trends in revenue and EPS, and analysts hold a positive outlook with a "Buy" consensus and potential upside, several factors warrant caution:

*   **Underperformance:** The stark divergence from the S&P 500, coupled with a negative Alpha in recent years, raises concerns about HON's growth and efficiency compared to the market. The long term expected return is extremely concerning.
*   **Technical Indicators:**  The stock price is below its 20-day and 60-day SMAs, suggesting a short-term downtrend.
*   **Mixed News:** Recent news headlines present a mixed picture, with a reduced price target countered by an institutional investment.
*   **Declining Equity:** Declining equity balance.

**Overall Recommendation:**

The "Buy" consensus from analysts and the improving earnings trends are encouraging. However, the significant underperformance relative to the S&P 500 and the concerning expected return suggest that a cautious approach is warranted. Investors should carefully evaluate the reasons for the underperformance and assess whether the company's growth strategy is likely to close the gap with the broader market. Further research into the factors driving the extremely negative expected return is critical. Considering the positive MRI and Hybrid Signal, while maintaining caution is warranted.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.